Arrowhead Research reported $323.72M in Current Assets for its fourth fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Agios Pharmaceuticals AGIO:US $ 636.68M 32.41M
Alnylam Pharmaceuticals ALNY:US $ 2614.78M 60.08M
Arena Pharmaceuticals ARNA:US $ 1139.31M 62.94M
Arrowhead Research ARWR:US $ 323.72M 1.35M
Bluebird Bio BLUE:US $ 1215.54M 77.66M
Cerulean Pharma CERU:US $ 6.98M 792.43K
Dicerna Pharmaceuticals DRNA:US $ 618.7M 8.95M
Heron Therapeutics HRTX:US $ 314.2M 36.8M
Intercept Pharmaceuticals ICPT:US $ 545.74M 15.35M
Ligand Pharmaceuticals LGND:US $ 500.56M 357.18M
Merk MRK:US $ 27764M 1187M
Mirati Therapeutics MRTX:US $ 1403.64M 808.25M
Moderna Inc MRNA:US 6.3B 2.72B
Nektar Therapeutics NKTR:US $ 1138.01M 94.15M
Novartis NOVN:VX 29.67B 700M
Opko Health OPK:US $ 523.18M 95.07M
Spectrum Pharmaceuticals SPPI:US $ 212.83M 37.79M
Ultragenyx Pharmaceutical RARE:US $ 1295.3M 423.3M
Vertex Pharmaceuticals VRTX:US $ 8133.38M 674.92M
Xencor XNCR:US $ 637.67M 66.79M
YTE INCY:US $ 2359.89M 200.47M